inhibitor M9 [PMID: 38236416]   Click here for help

GtoPdb Ligand ID: 13113

Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: This compound is an orally bioavailable dual inhibitor of soluble epoxide hydrolase (sEH; EPHX2) and histone deacetylase 6 (HDAC6) [1]. It combines the target-specific pharmacophores of the sEH inhibitor AR-9281 and the HDAC6 inhibitor ricolinostat. M9 was designed to provide an analgesic effect for application in neuropathic pain and inflammatory conditions.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 5
Rotatable bonds 14
Topological polar surface area 119.56
Molecular weight 484.63
XLogP 3.98
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C[C@@]12C[C@H]3C[C@@](C)(C1)C[C@](C3)(C2)NC(=O)NC4=CC=C(C=C4)C(=O)NCCCCCCC(=O)NO
Isomeric SMILES O=C(NC1=CC=C(C(NCCCCCCC(NO)=O)=O)C=C1)N[C@]23C[C@H]4C[C@@](C[C@](C2)(C)C4)(C)C3
InChI InChI=1S/C27H40N4O4/c1-25-13-19-14-26(2,16-25)18-27(15-19,17-25)30-24(34)29-21-10-8-20(9-11-21)23(33)28-12-6-4-3-5-7-22(32)31-35/h8-11,19,35H,3-7,12-18H2,1-2H3,(H,28,33)(H,31,32)(H2,29,30,34)/t19-,25+,26-,27-
InChI Key LICDGBVIDDVNJZ-IIEILYMYSA-N
References
1. Chen Y, Sun J, Tong H, Wang J, Cao R, Xu H, Chen L, Morisseau C, Zhang M, Shi Y et al.. (2024)
Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality.
J Med Chem, 67 (3): 2095-2117. [PMID:38236416]